* Quanterix Corp reported a quarterly adjusted loss of 26 cents per share for the quarter ended in January, lower than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of four analysts for the quarter was for a loss of 31 cents per share. Wall Street expected results to range from -36 cents to -27 cents per share.
* Revenue rose 12.7% to $32.07 million from a year ago; analysts expected $31.62 million.
* Quanterix Corp's reported EPS for the quarter was a loss of 26 cents.
* The company reported a quarterly loss of $10.07 million.
* Quanterix Corp shares had fallen by 28.7% this quarter and lost 38.6% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 6.8% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Quanterix Corp is $30.00 This summary was machine generated from LSEG data May 7 at 09:39 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.31 -0.26 Beat
Dec. 31 2023 -0.32 -0.33 Missed
Sep. 30 2023 -0.37 -0.21 Beat
Jun. 30 2023 -0.38 -0.16 Beat
Comments